Table 2. Area of decreased autofluorescence and functional measurement.
| Patients |
DDAF (mm2) |
QDAF (mm2) |
Visual field |
Dark-adapted 0.01 ERG |
Light-adapted 3 ERG |
||||
|---|---|---|---|---|---|---|---|---|---|
| ID | Right | Left | Right | Left | (method) | Rod amp | Rod IT | Cone amp | Cone IT |
| H27 |
0.13 |
0 |
0.13 |
1.68 |
≤10° CS (GVF) |
1.93 |
0.79 |
2.03 |
0.97 |
| H62 |
NA |
NA |
NA |
NA |
NA |
1.12 |
0.97 |
1.5 |
1.05 |
| H75 |
6.84 |
6.61 |
12.3 |
13.34 |
≤20° CS (GVF) |
1.75 |
0.99 |
0.72 |
0.98 |
| H147 |
NA |
NA |
NA |
NA |
≤10° CS (GVF) |
0.57 |
1.08 |
0.75 |
1 |
| H148 |
NA |
NA |
NA |
NA |
≤5° CS (GVF) |
1.02 |
1.14 |
0.7 |
1.04 |
| H234 |
0 |
0 |
2.67 |
2.46 |
≤5° CS (HVF) |
0.48 |
1.02 |
1.29 |
0.92 |
| H278 |
0.58 |
0.44 |
8.19 |
8.08 |
≤10° CS (HVF) |
3.04 |
1.03 |
4.8 |
0.95 |
| H830 |
0 |
0 |
0 |
0 |
Normal |
0.84 |
1.12 |
2.49 |
0.92 |
| H91 |
NA |
NA |
NA |
NA |
Extrafoveal VF island |
0 |
0 |
0 |
0 |
| H144 |
EA |
EA |
EA |
EA |
No detected |
0.43 |
1.25 |
0.64 |
0.83 |
| H145 | EA | EA | EA | EA | No detected | 0.41 | 1.29 | 0.53 | 1.09 |
DDAF, definitely decreased autofluorescence; QDAF, questionably decreased autofluorescence; GVF, Goldmann visual field test (III4e); HVF, Humphery visual field 24–2; amp, the ratio of b-wave amplitude compared to the normative value; IT, the ratio of b-wave implicit time compared to the normative value; NA, not applicable; CS, central scotoma; EA, the entire macula